跳至主要内容
临床试验/NCT02418871
NCT02418871已完成不适用

Clinical Evaluation of the FluidVision Accommodating Intraocular Lens With an Improved Injector System

PowerVision5 个研究点 分布在 2 个国家目标入组 53 人开始时间: 2015年3月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
PowerVision
入组人数
53
试验地点
5
主要终点
Accommodative amplitude

研究概览

简要总结

The purpose of this study is to evaluate the clinical outcomes of an investigational IOL in patients undergoing cataract extraction and intraocular lens implantation using an improved injector system.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eligible for primary intraocular lens implantation for the correction of aphakia following cataract extraction;
  • Best corrected distance visual acuity worse than 20/40 either with or without a glare source present (e.g. Brightness Acuity Tester);
  • Less than or equal to 1.0 diopter (D) of preoperative keratometric astigmatism;
  • Willing and able to comply with schedule for follow-up visits for 36 months after surgery.
  • Other protocol-defined inclusion criteria may apply.

排除标准

  • Systemic disease that could increase the operative risk or confound the outcome (e.g. autoimmune disease, diabetes);
  • Taking systemic medications that may confound the outcome or increase the risk to the subject;
  • Ocular conditions that may predispose for future complications;
  • Previous intraocular or corneal surgery that might confound the outcome of the investigation or increase the risk to the subject;
  • Pregnant, lactating during the course of the investigation, or with another condition associated with fluctuation of hormones that could lead to refractive changes;
  • Diagnosed degenerative visual disorders (e.g. macular degeneration or other retinal disorders) that are predicted to cause future best corrected visual acuity loss worse than 20/
  • Other protocol-defined exclusion criteria may apply.

结局指标

主要结局

Accommodative amplitude

时间窗: Month 6

Accommodative amplitude is a measure of the ability of the eye to focus from a target that is at distance into a target that is near.

Best corrected distance visual acuity (BCDVA)

时间窗: Month 6

Visual acuity of the eye will be tested with the correction in place.

Rates of adverse events

时间窗: Up to Month 36

Adverse events will be collected from time of enrollment to study exit.

次要结局

未报告次要终点

研究者

发起方
PowerVision
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验

Evaluation of the FluidVision Accommodating... | 临床试验